Concepedia

Schedule Iii Classification

Schedule III Classification is a regulatory category within the framework of controlled substance scheduling that distinguishes substances with a moderately low potential for physical dependence or a high potential for psychological dependence, thereby permitting medical use under accepted safety protocols, in contrast to the more restrictive classifications of Schedules I and II.

5

Publications

196

Citations

22

Authors

7

Institutions

Publications per year

2017–2026

3

Parents

Publications

5

Decline in opioid prescribing after federal rescheduling of hydrocodone products

Mukaila A. Raji, Yong‐Fang Kuo, Deepak Adhikari et al. · Pharmacoepidemiology and Drug Safety · 2017 · 62 citations · Full text

, , +17

Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.

Patricia LoRusso, Antoinette J. Wozniak, Lisa Polin et al. · PubMed · 1990 · 53 citations

, , +14

Opioid Prescriptions in Older Medicare Beneficiaries After the 2014 Federal Rescheduling of Hydrocodone Products

Mukaila A. Raji, Victor Liaw, Jacques Baillargeon et al. · Journal of the American Geriatrics Society · 2018 · 35 citations

, , +16

SPORTS ILLUSTRATED, THE “WAR ON DRUGS,” AND THE ANABOLIC STEROID CONTROL ACT OF 1990

Bryan E. Denham · Journal of Sport and Social Issues · 1997 · 33 citations

, , +17

The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System

Thomas F. Northrup, Kelley Carroll, Robert Suchting et al. · The Journal of the American Board of Family Medicine · 2019 · 13 citations · Full text

, , +17

1–5 of 5

Authors

22

  1. JS
    James S. Goodwin

    The University of Texas Medical Branch at Galveston, United States

    2 publications · 97 citations

    2

    h-index

  2. MA
    Mukaila A. Raji

    The University of Texas Medical Branch at Galveston, United States

    2 publications · 97 citations

    2

    h-index

  3. JB
    Jacques Baillargeon

    The University of Texas Medical Branch at Galveston, United States

    2 publications · 97 citations

    2

    h-index

  4. VL
    Victor Liaw

    The University of Texas Medical Branch at Galveston, United States

    1 publications · 35 citations

    1

    h-index

  5. BE
    Bryan E. Denham

    Clemson University, United States

    1 publications · 33 citations

    1

    h-index

1–5 of 22

Institutions

7

  1. The University of Texas Medical Branch at Galveston

    Galveston, United States

    2 h-index

    9 publications

    450 citations

  2. Wayne State University

    Detroit, United States

    1 h-index

    4 publications

    212 citations

  3. Grady Health System

    Atlanta, United States

    1 h-index

    6 publications

    78 citations

  4. The University of Texas Health Science Center at Houston

    Houston, United States

    1 h-index

    6 publications

    78 citations

  5. The University of Texas at Austin

    Austin, United States

    1 h-index

    1 publications

    35 citations

  6. Pfizer (United States)

    New York, United States

    1 h-index

    3 publications

    159 citations

1–6 of 7

Venues

  1. The Journal of the American Board of Family Medicine

    JABFM · 1 publications · 13 citations

    1

    h-index

  2. Journal of Sport and Social Issues

    JSSI · 1 publications · 33 citations

    1

    h-index

  3. Journal of the American Geriatrics Society

    1 publications · 35 citations

    1

    h-index

  4. Pharmacoepidemiology and Drug Safety

    1 publications · 62 citations

    1

    h-index

  5. PubMed

    Repository · 1 publications · 53 citations

    1

    h-index

1–5